The skeletal response to estrogen is impaired in female but not in male steroid receptor coactivator (SRC)-1 knock out mice

U. I. Mödder, A. Sanyal, J. Xu, B. W. O'Malley, T. C. Spelsberg, Sundeep Khosla

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Estrogen (E) is critical for the maintenance of bone mass in both female and male mice and steroid receptor coactivator (SRC)-1 has been shown to be important for mediating E effects on bone, at least in female mice. In the present study, we defined the skeletal phenotype of male SRC-1 knock out (KO) mice and compared it with their female littermates. Further, to determine the role of SRC-1 in mediating effects of E on bone in male mice, we examined the skeletal effects of gonadectomy (gnx) with or without E replacement in male mice and placed these findings in the context of our previous studies in female SRC-1 KO mice. Analysis of a large group of male (WT, n = 67; SRC-1 KO, n = 56) and female (WT, n = 66; SRC-1 KO, n = 70) mice showed a significant decrease in trabecular volumetric bone mineral density (vBMD) in SRC-1 KO mice compared to their WT littermates in both genders (male SRC-1 KO, 275 ± 3 vs. WT, 295 ± 3 mg/cm 3, P < 0.001; female SRC-1 KO, 210 ± 2 vs. WT, 221 ± 2 mg/cm 3, P < 0.001). Following gnx and E replacement (10 μg/kg/day), we previously demonstrated that SRC-1 KO female mice have a defect in E action in trabecular, but not in cortical bone. In contrast, we now demonstrate that the same dose of E administered to gnx'd male SRC-1 KO mice was sufficient to prevent trabecular bone loss in these mice. For example, in WT female mice, gnx followed by E replacement maintained spine BMD (1.2 ± 3.4% vs. baseline) as compared to gnx without E replacement (- 12.7 ± 2.6%, P < 0.001 vs. sham); this effect of E was absent in SRC-1 KO female mice. By contrast, the identical dose of E was equally effective in maintaining spine BMD in E-treated gnx'd male WT (- 5.2 ± 5.1% vs. baseline) and male SRC-1 KO (- 5.4 ± 5.3%) mice, respectively, as compared to gnx'd mice without E treatment (WT, - 17.6 ± 2.5%, P = 0.02; SRC-1 KO, - 28.6 ± 2.6%, P < 0.001 vs. sham). E treatment was effective in suppressing cancellous bone turnover in both gnx'd WT and SRC-1 KO male mice as determined by significant reductions in osteoblast and osteoclast numbers; however, in female mice, E treatment only suppressed bone turnover in WT but not in SRC-1 KO mice. Collectively, these findings demonstrate that loss of SRC-1 results in trabecular osteopenia in male and female mice, but in contrast to female mice, this is not due to any detectable resistance to E action in trabecular bone in male SRC-1 KO mice.

Original languageEnglish (US)
Pages (from-to)414-421
Number of pages8
JournalBone
Volume42
Issue number2
DOIs
StatePublished - Feb 2008

Fingerprint

Nuclear Receptor Coactivator 1
Knockout Mice
Estrogens
Bone Remodeling
Bone and Bones
Spine

Keywords

  • E action
  • Gender difference
  • Gonadectomy
  • SRC
  • Steroid receptor coactivators

ASJC Scopus subject areas

  • Physiology
  • Hematology

Cite this

The skeletal response to estrogen is impaired in female but not in male steroid receptor coactivator (SRC)-1 knock out mice. / Mödder, U. I.; Sanyal, A.; Xu, J.; O&apos;Malley, B. W.; Spelsberg, T. C.; Khosla, Sundeep.

In: Bone, Vol. 42, No. 2, 02.2008, p. 414-421.

Research output: Contribution to journalArticle

Mödder, U. I. ; Sanyal, A. ; Xu, J. ; O&apos;Malley, B. W. ; Spelsberg, T. C. ; Khosla, Sundeep. / The skeletal response to estrogen is impaired in female but not in male steroid receptor coactivator (SRC)-1 knock out mice. In: Bone. 2008 ; Vol. 42, No. 2. pp. 414-421.
@article{d536fe1e2bdb494e8d0d82058c0f1a3b,
title = "The skeletal response to estrogen is impaired in female but not in male steroid receptor coactivator (SRC)-1 knock out mice",
abstract = "Estrogen (E) is critical for the maintenance of bone mass in both female and male mice and steroid receptor coactivator (SRC)-1 has been shown to be important for mediating E effects on bone, at least in female mice. In the present study, we defined the skeletal phenotype of male SRC-1 knock out (KO) mice and compared it with their female littermates. Further, to determine the role of SRC-1 in mediating effects of E on bone in male mice, we examined the skeletal effects of gonadectomy (gnx) with or without E replacement in male mice and placed these findings in the context of our previous studies in female SRC-1 KO mice. Analysis of a large group of male (WT, n = 67; SRC-1 KO, n = 56) and female (WT, n = 66; SRC-1 KO, n = 70) mice showed a significant decrease in trabecular volumetric bone mineral density (vBMD) in SRC-1 KO mice compared to their WT littermates in both genders (male SRC-1 KO, 275 ± 3 vs. WT, 295 ± 3 mg/cm 3, P < 0.001; female SRC-1 KO, 210 ± 2 vs. WT, 221 ± 2 mg/cm 3, P < 0.001). Following gnx and E replacement (10 μg/kg/day), we previously demonstrated that SRC-1 KO female mice have a defect in E action in trabecular, but not in cortical bone. In contrast, we now demonstrate that the same dose of E administered to gnx'd male SRC-1 KO mice was sufficient to prevent trabecular bone loss in these mice. For example, in WT female mice, gnx followed by E replacement maintained spine BMD (1.2 ± 3.4{\%} vs. baseline) as compared to gnx without E replacement (- 12.7 ± 2.6{\%}, P < 0.001 vs. sham); this effect of E was absent in SRC-1 KO female mice. By contrast, the identical dose of E was equally effective in maintaining spine BMD in E-treated gnx'd male WT (- 5.2 ± 5.1{\%} vs. baseline) and male SRC-1 KO (- 5.4 ± 5.3{\%}) mice, respectively, as compared to gnx'd mice without E treatment (WT, - 17.6 ± 2.5{\%}, P = 0.02; SRC-1 KO, - 28.6 ± 2.6{\%}, P < 0.001 vs. sham). E treatment was effective in suppressing cancellous bone turnover in both gnx'd WT and SRC-1 KO male mice as determined by significant reductions in osteoblast and osteoclast numbers; however, in female mice, E treatment only suppressed bone turnover in WT but not in SRC-1 KO mice. Collectively, these findings demonstrate that loss of SRC-1 results in trabecular osteopenia in male and female mice, but in contrast to female mice, this is not due to any detectable resistance to E action in trabecular bone in male SRC-1 KO mice.",
keywords = "E action, Gender difference, Gonadectomy, SRC, Steroid receptor coactivators",
author = "M{\"o}dder, {U. I.} and A. Sanyal and J. Xu and O&apos;Malley, {B. W.} and Spelsberg, {T. C.} and Sundeep Khosla",
year = "2008",
month = "2",
doi = "10.1016/j.bone.2007.10.017",
language = "English (US)",
volume = "42",
pages = "414--421",
journal = "Bone",
issn = "8756-3282",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - The skeletal response to estrogen is impaired in female but not in male steroid receptor coactivator (SRC)-1 knock out mice

AU - Mödder, U. I.

AU - Sanyal, A.

AU - Xu, J.

AU - O&apos;Malley, B. W.

AU - Spelsberg, T. C.

AU - Khosla, Sundeep

PY - 2008/2

Y1 - 2008/2

N2 - Estrogen (E) is critical for the maintenance of bone mass in both female and male mice and steroid receptor coactivator (SRC)-1 has been shown to be important for mediating E effects on bone, at least in female mice. In the present study, we defined the skeletal phenotype of male SRC-1 knock out (KO) mice and compared it with their female littermates. Further, to determine the role of SRC-1 in mediating effects of E on bone in male mice, we examined the skeletal effects of gonadectomy (gnx) with or without E replacement in male mice and placed these findings in the context of our previous studies in female SRC-1 KO mice. Analysis of a large group of male (WT, n = 67; SRC-1 KO, n = 56) and female (WT, n = 66; SRC-1 KO, n = 70) mice showed a significant decrease in trabecular volumetric bone mineral density (vBMD) in SRC-1 KO mice compared to their WT littermates in both genders (male SRC-1 KO, 275 ± 3 vs. WT, 295 ± 3 mg/cm 3, P < 0.001; female SRC-1 KO, 210 ± 2 vs. WT, 221 ± 2 mg/cm 3, P < 0.001). Following gnx and E replacement (10 μg/kg/day), we previously demonstrated that SRC-1 KO female mice have a defect in E action in trabecular, but not in cortical bone. In contrast, we now demonstrate that the same dose of E administered to gnx'd male SRC-1 KO mice was sufficient to prevent trabecular bone loss in these mice. For example, in WT female mice, gnx followed by E replacement maintained spine BMD (1.2 ± 3.4% vs. baseline) as compared to gnx without E replacement (- 12.7 ± 2.6%, P < 0.001 vs. sham); this effect of E was absent in SRC-1 KO female mice. By contrast, the identical dose of E was equally effective in maintaining spine BMD in E-treated gnx'd male WT (- 5.2 ± 5.1% vs. baseline) and male SRC-1 KO (- 5.4 ± 5.3%) mice, respectively, as compared to gnx'd mice without E treatment (WT, - 17.6 ± 2.5%, P = 0.02; SRC-1 KO, - 28.6 ± 2.6%, P < 0.001 vs. sham). E treatment was effective in suppressing cancellous bone turnover in both gnx'd WT and SRC-1 KO male mice as determined by significant reductions in osteoblast and osteoclast numbers; however, in female mice, E treatment only suppressed bone turnover in WT but not in SRC-1 KO mice. Collectively, these findings demonstrate that loss of SRC-1 results in trabecular osteopenia in male and female mice, but in contrast to female mice, this is not due to any detectable resistance to E action in trabecular bone in male SRC-1 KO mice.

AB - Estrogen (E) is critical for the maintenance of bone mass in both female and male mice and steroid receptor coactivator (SRC)-1 has been shown to be important for mediating E effects on bone, at least in female mice. In the present study, we defined the skeletal phenotype of male SRC-1 knock out (KO) mice and compared it with their female littermates. Further, to determine the role of SRC-1 in mediating effects of E on bone in male mice, we examined the skeletal effects of gonadectomy (gnx) with or without E replacement in male mice and placed these findings in the context of our previous studies in female SRC-1 KO mice. Analysis of a large group of male (WT, n = 67; SRC-1 KO, n = 56) and female (WT, n = 66; SRC-1 KO, n = 70) mice showed a significant decrease in trabecular volumetric bone mineral density (vBMD) in SRC-1 KO mice compared to their WT littermates in both genders (male SRC-1 KO, 275 ± 3 vs. WT, 295 ± 3 mg/cm 3, P < 0.001; female SRC-1 KO, 210 ± 2 vs. WT, 221 ± 2 mg/cm 3, P < 0.001). Following gnx and E replacement (10 μg/kg/day), we previously demonstrated that SRC-1 KO female mice have a defect in E action in trabecular, but not in cortical bone. In contrast, we now demonstrate that the same dose of E administered to gnx'd male SRC-1 KO mice was sufficient to prevent trabecular bone loss in these mice. For example, in WT female mice, gnx followed by E replacement maintained spine BMD (1.2 ± 3.4% vs. baseline) as compared to gnx without E replacement (- 12.7 ± 2.6%, P < 0.001 vs. sham); this effect of E was absent in SRC-1 KO female mice. By contrast, the identical dose of E was equally effective in maintaining spine BMD in E-treated gnx'd male WT (- 5.2 ± 5.1% vs. baseline) and male SRC-1 KO (- 5.4 ± 5.3%) mice, respectively, as compared to gnx'd mice without E treatment (WT, - 17.6 ± 2.5%, P = 0.02; SRC-1 KO, - 28.6 ± 2.6%, P < 0.001 vs. sham). E treatment was effective in suppressing cancellous bone turnover in both gnx'd WT and SRC-1 KO male mice as determined by significant reductions in osteoblast and osteoclast numbers; however, in female mice, E treatment only suppressed bone turnover in WT but not in SRC-1 KO mice. Collectively, these findings demonstrate that loss of SRC-1 results in trabecular osteopenia in male and female mice, but in contrast to female mice, this is not due to any detectable resistance to E action in trabecular bone in male SRC-1 KO mice.

KW - E action

KW - Gender difference

KW - Gonadectomy

KW - SRC

KW - Steroid receptor coactivators

UR - http://www.scopus.com/inward/record.url?scp=37849026542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37849026542&partnerID=8YFLogxK

U2 - 10.1016/j.bone.2007.10.017

DO - 10.1016/j.bone.2007.10.017

M3 - Article

C2 - 18055287

AN - SCOPUS:37849026542

VL - 42

SP - 414

EP - 421

JO - Bone

JF - Bone

SN - 8756-3282

IS - 2

ER -